Conditional inference in cis-Mendelian randomization using weak genetic factors

Ashish Patel,Dipender Gill,Paul J. Newcombe,Stephen Burgess

DOI: https://doi.org/10.48550/arXiv.2005.01765

2021-12-31

Abstract:Mendelian randomization is a widely-used method to estimate the unconfounded effect of an exposure on an outcome by using genetic variants as instrumental variables. Mendelian randomization analyses which use variants from a single genetic region (cis-MR) have gained popularity for being an economical way to provide supporting evidence for drug target validation. This paper proposes methods for cis-MR inference which use the explanatory power of many correlated variants to make valid inferences even in situations where those variants only have weak effects on the exposure. In particular, we exploit the highly structured nature of genetic correlations in single gene regions to reduce the dimension of genetic variants using factor analysis. These genetic factors are then used as instrumental variables to construct tests for the causal effect of interest. Since these factors may often be weakly associated with the exposure, size distortions of standard t-tests can be severe. Therefore, we consider two approaches based on conditional testing. First, we extend results of commonly-used identification-robust tests to account for the use of estimated factors as instruments. Secondly, we propose a test which appropriately adjusts for first-stage screening of genetic factors based on their relevance. Our empirical results provide genetic evidence to validate cholesterol-lowering drug targets aimed at preventing coronary heart disease.

Methodology

What problem does this paper attempt to address?

The paper attempts to address the issue of making conditional inferences using weak genetic factors in single-gene regions (cis-Mendelian randomization, abbreviated as cis-MR). Specifically, the paper proposes a method that utilizes the explanatory power of multiple related genetic variants to make effective causal inferences, even if these variants have a weak impact on the exposure variable. The focus of the research is on developing statistical testing methods that remain effective even in the presence of weak genetic signals, to support the analysis of genetic evidence in the drug target validation process.

Specifically, the paper focuses on the following points:
1. **Weak Instrument Problem**: In cis-MR analysis, traditional methods may be biased due to small sample sizes or weak genetic associations. Therefore, the paper proposes several methods to address this challenge.
2. **Factor Analysis**: Reducing the dimensionality of genetic variants through factor analysis and using the estimated genetic factors as instrumental variables to test causal effects.
3. **Conditional Testing Methods**: Proposing two conditional testing methods, one extending commonly used identification robustness tests (such as the Anderson-Rubin test), and the other adjusting the conditional tests during the first-stage screening of genetic factors.

The ultimate goal is to obtain reliable causal inference results even when dealing with small sample sizes and weak genetic associations, and to apply these results to practical cases, such as validating the effectiveness of cholesteryl ester transfer protein (CETP) inhibitors as potential drug targets for the prevention of coronary heart disease.